Your browser doesn't support javascript.
loading
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Verstovsek, Srdan; Foltz, Lynda; Gupta, Vikas; Hasserjian, Robert; Manshouri, Taghi; Mascarenhas, John; Mesa, Ruben; Pozdnyakova, Olga; Ritchie, Ellen; Veletic, Ivo; Gamel, Katia; Hamidi, Habib; Han, Lyrialle; Higgins, Brian; Trunzer, Kerstin; Uguen, Marianne; Wang, Dao; El-Galaly, Tarec Christoffer; Todorov, Boyan; Gotlib, Jason.
Afiliação
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. sverstovsek@kartosthera.com.
  • Foltz L; St Paul's Hospital, University of British Columbia, Vancouver.
  • Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto.
  • Hasserjian R; Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Manshouri T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Mesa R; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX.
  • Pozdnyakova O; Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Ritchie E; Weill Cornell Medicine, New York, NY.
  • Veletic I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Gamel K; F. Hoffmann-La Roche, Ltd., Basel.
  • Hamidi H; Genentech Inc, South San Francisco, CA.
  • Han L; Genentech Inc, South San Francisco, CA.
  • Higgins B; Genentech Inc, South San Francisco, CA.
  • Trunzer K; F. Hoffmann-La Roche, Ltd., Basel.
  • Uguen M; F. Hoffmann-La Roche, Ltd., Basel.
  • Wang D; F. Hoffmann-La Roche, Ltd., Basel.
  • El-Galaly TC; F. Hoffmann-La Roche, Ltd., Basel, Switzerland; Current affiliation: Department of Hematology, Aalborg University Hospital, Aalborg.
  • Todorov B; F. Hoffmann-La Roche, Ltd., Basel.
  • Gotlib J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA.
Haematologica ; 108(10): 2730-2742, 2023 10 01.
Article em En | MEDLINE | ID: mdl-37165840
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Mielofibrose Primária Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Mielofibrose Primária Idioma: En Ano de publicação: 2023 Tipo de documento: Article